Classification of Bone Tumors - Tumor Blueprint
-
Fundamental Principles:
- Histogenesis (Cell of Origin): E.g., Osteogenic (bone-forming), Chondrogenic (cartilage-forming), Fibrogenic, Hematopoietic (marrow cells), Vascular.
- Biological Behavior:
- Benign (e.g., Osteoma, Enchondroma)
- Intermediate (locally aggressive, e.g., Giant Cell Tumor; or rarely metastasizing)
- Malignant (e.g., Osteosarcoma, Chondrosarcoma, Ewing Sarcoma)
- Origin: Primary (arises in bone) vs. Secondary (metastatic, e.g., from breast, lung, prostate).
-
WHO Classification: International standard, integrates morphology, genetics, and clinical behavior.
⭐ Osteosarcoma is the most common non-hematopoietic primary malignant bone tumor, typically affecting metaphysis of long bones in adolescents.
Classification of Bone Tumors - Gentle Giants
- Osteogenic (Bone-forming):
- Osteoid Osteoma: < 2 cm, night pain (NSAID relief), nidus.
- Osteoblastoma: > 2 cm, similar histology, less pain. Spine common.
- Chondrogenic (Cartilage-forming):
- Osteochondroma: Most common. Cartilage-capped exostosis (metaphysis). 📌 Mnemonic: "Osteo-CONE-droma" (cone-shaped).
- Enchondroma: Medullary cartilage. Hands/feet. Ollier's, Maffucci's.
- Chondroblastoma: Epiphyseal. "Chicken-wire" calcification.
- Fibrogenic:
- Non-Ossifying Fibroma (NOF): Children, eccentric, lytic, sclerotic rim.
- Other Origin:
- Giant Cell Tumor (GCT): Epiphyseal (mature). Locally aggressive. "Soap bubble".
- Aneurysmal Bone Cyst (ABC): Expansile, lytic, blood-filled spaces. Fluid-fluid levels on MRI.

⭐ Osteoid Osteoma classically presents with nocturnal pain dramatically relieved by NSAIDs/aspirin.
Classification of Bone Tumors - Bone Breakers
- Primary Malignant Tumors: Arise from bone/cartilage.
- Osteosarcoma: Most common (excl. myeloma); bone-forming.
- Age: 10-20 yrs (peak), also >50 yrs.
- Sites: Metaphysis (knee, proximal humerus).
- X-ray: Sunburst, Codman's triangle.
- Ewing Sarcoma: Small round blue cell tumor; aggressive.
- Age: 10-20 yrs.
- Sites: Diaphysis (long bones, pelvis).
- X-ray: Onion-peel, moth-eaten.
- Genetics: t(11;22) EWS-FLI1.
- Chondrosarcoma: Cartilage-producing malignancy.
- Age: >40 yrs.
- Sites: Pelvis, femur, ribs.
- X-ray: Popcorn/ring-and-arc calcification.
- Others:
- Fibrosarcoma/MFH (spindle cell)
- Malignant GCT (rare transformation)
- Chordoma (notochordal; sacrum, clivus)
- Adamantinoma (low-grade; tibia)
- Osteosarcoma: Most common (excl. myeloma); bone-forming.
⭐ Ewing Sarcoma is highly radiosensitive & chemosensitive, unlike Osteosarcoma (radioresistant; surgery + chemo primary).
Classification of Bone Tumors - Masqueraders & Invaders
- Masqueraders (Tumor-like Lesions): Mimic tumors; non-neoplastic.
- Fibrous Dysplasia: Ground-glass appearance, Shepherd's crook deformity.
- Simple Bone Cyst (SBC/UBC): Central, lytic, "fallen leaf" sign.
- Aneurysmal Bone Cyst (ABC): Eccentric, expansile, blood-filled; fluid-fluid levels.
- Brown Tumor: Due to hyperparathyroidism.
- Osteomyelitis: Bone infection.
- Eosinophilic Granuloma (LCH): Vertebra plana, punched-out lytic lesions.
- Invaders (Metastatic Disease):
- Most common bone malignancy overall.
- Common Primaries: 📌 PBL KT (Prostate, Breast, Lung, Kidney, Thyroid).
- Radiographic Types: Lytic (e.g., Lung, Kidney), Sclerotic/Blastic (e.g., Prostate), Mixed (e.g., Breast).
⭐ Metastasis is the most common malignant tumor affecting bone.
oka
High‑Yield Points - ⚡ Biggest Takeaways
- Primary division: Benign versus Malignant, dictates management approach.
- Histogenetic origin (osteogenic, chondrogenic, fibrogenic, hematopoietic) is crucial for classification.
- Patient age and tumor location (epiphysis, metaphysis, diaphysis) are vital diagnostic clues.
- Osteosarcoma: Most common primary malignant tumor, typically in metaphysis around knee.
- Ewing's Sarcoma: Pediatric diaphysis tumor, classic "onion-skin" periosteal reaction.
- Giant Cell Tumor (GCT): Locally aggressive, epiphyseal location, characteristic "soap bubble" appearance.
- Multiple Myeloma: Most common overall malignant bone tumor in adults (plasma cell origin).
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app